NYSE · Industrials
ASPEN AEROGELS INC (ASPN)
As-reported financials and recent SEC filings for ASPEN AEROGELS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$271.1M
Net income
$-389.6M
Net margin
-143.7%
Diluted EPS
$-4.73
ROE
-165.4%
P/E (TTM)
—
Market cap
$466.6M
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $271.1M | $452.7M | $238.7M | $180.4M | $121.6M |
| Gross profit | $46.0M | $182.9M | $56.9M | $5.0M | $9.9M |
| Operating income | $-378.2M | $54.5M | $-49.2M | $-79.2M | $-40.6M |
| Net income | $-389.6M | $13.4M | $-45.8M | $-82.7M | $-37.1M |
| Diluted EPS | $-4.73 | $0.17 | $-0.66 | $-2.10 | $-1.22 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →8-K2026-05-18
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →10-Q2026-05-08
View on EDGAR →Go deeper on ASPN
Search ASPEN AEROGELS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.